Emerald Health Pharmaceuticals (EHP) is a biotech company that provides medicines based on cannabinoid science. It develops pharmaceutical compounds to treat a range of diseases, including neurodegenerative, auto-immune, inflammatory, fibrotic, cardiovascular, and metabolic disorders. The company's technology platform is based on the use of new chemical entities (NCEs) derived from synthetic cannabidiol (CBD) and cannabigerol (CBG).